Tagged With Axovant

The CEO of a biotech founded by a 32-year old is stepping down after 10 months -- and the stock is crashing


A biotech founded by a 32-year-old just hit another setback -- and the stock got chopped in half


A biotech founded by a 32-year-old just failed a key Alzheimer's drug trial



A biotech CEO who sold his last company for $14 billion explains why he wants to do things differently this time


A biotech CEO who sold his last company for $14 billion shares his best career advice


A biotech CEO who sold his last company for $14 billion explains what it takes to build a company



A biotech founded by a 32-year-old has a shot to launch 'the first new Alzheimer's drug in 15 years'


A company developing a drug to treat Alzheimer's disease just got a new CEO -- and the stock is jumping


This 30-year-old CEO just launched the one critical test his Alzheimer's drug needs for approval


10 game-changing drug companies that are about to revolutionise how we treat illness


This 29-year-old CEO's Alzheimer's drug is one critical clinical trial away from getting approval